Noah Federman, H. David S. Ulmert, Johannes Czernin, Arun S. Singh, Mohamed Altai, Brian Turpin, Matteo Maria Trucco, Kristen VanHeyst, David J. Hoogstra, Brian Andrew Van Tine, Marc S. Rudoltz, Chao Wang, Aseem Anand, David Stephen Shulman. "A phase 1/2, multi-center, open-label study to evaluate the safety, tolerability, pharmacokinetics, radiation dosimetry, and preliminary anti-neoplastic activity of LNTH-2403, a LRRC15-targeted
                    <sup>177</sup>
                    lutetium-labeled monoclonal antibody, in patients with relapsed/refractory osteosarcoma.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.tps11587